Antibody therapies can remove amyloid plaques from the brain and slow cognitive decline in people with Alzheimer's disease ...
HD heads into Q4 results with sales and EPS expected to be down y/y, but GMS contributions and Pro demand are likely to shape whether HD delivers a surprise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results